日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multimodal Deep Learning with Routine Clinical Data for Recurrence Risk Stratification in HR(+)/HER2(-) Early Breast Cancer

利用常规临床数据进行多模态深度学习，对HR(+)/HER2(-)早期乳腺癌进行复发风险分层

期刊:
影响因子:
doi:10.34133/research.1136
Wu, Xiaoyan; Liu, Hong; Liu, Jingyan; Mu, Bing'an; Li, Jianfei; Wang, Siyu; Li, Fengling; Lu, Xunxi; Chen, Jie; Peng, Yulan; Yi, Yuhao; Lv, Jiancheng; Bu, Hong
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Development and validation of a 10-gene signature for predicting recurrence risk in HR+/HER2- early breast cancer undergoing chemo-endocrine therapy

开发和验证用于预测接受化疗-内分泌治疗的 HR+/HER2- 早期乳腺癌复发风险的 10 基因特征

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104484
Wu, Xiaoyan; Lu, Xunxi; Zhang, Wenchuan; Zhong, Xiaorong; Bu, Hong; Zhang, Zhang
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection

与SARS-CoV-2再感染相关的T细胞受体库的独特特征

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1680089
Zeng, Liling; Liu, Li; Ren, Baolin; Feng, Bing; Lai, Xudong; Lai, Xunxi; Chen, Zhimin; Huang, Yihui; Hong, Wenxin
SARS-CoV-2
T细胞
炎症/感染
信号转导
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Multimodal recurrence risk prediction model for HR+/HER2- early breast cancer following adjuvant chemo-endocrine therapy: integrating pathology image and clinicalpathological features

针对接受辅助化疗内分泌治疗的HR+/HER2-早期乳腺癌的多模态复发风险预测模型：整合病理影像和临床病理特征

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-01968-0
Wu, Xiaoyan; Li, Yiman; Chen, Jilong; Chen, Jie; Zhang, Wenchuan; Lu, Xunxi; Zhong, Xiaorong; Zhu, Min; Yi, Yuhao; Bu, Hong
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Attention-based multimodal fusion transformer for predicting the efficacy of neoadjuvant therapy in breast cancer: a cross-institutional retrospective study

基于注意力机制的多模态融合转换器预测乳腺癌新辅助治疗的疗效：一项跨机构回顾性研究

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02181-9
Zhang, Wenchuan; Zhang, Shuwan; You, Jiadi; Li, Fengling; Wu, Xiaoyan; Lu, Xunxi; Lv, Qingjie; Huang, Juan; Yi, Yuhao; Bu, Hong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

AI microscope facilitates accurate interpretation of HER2 immunohistochemical scores 0 and 1+ in invasive breast cancer

AI显微镜有助于准确解读浸润性乳腺癌中HER2免疫组化评分0和1+

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-13820-8
La, Zong; Chen, Jie; Lu, Xunxi; Lei, Chuanfen; Li, Fengling; Zhao, Lin; Yi, Yuhao
乳腺癌
HER2
免疫/内分泌
肿瘤
IHC
肿瘤免疫
发表日期：2025
文献求助 收藏

GPER Enhances Chronic Burn Pain via PKC-Mediated Mu-Opioid Receptor Phosphorylation in the Rostral Ventromedial Medulla

GPER通过PKC介导的延髓腹内侧部μ-阿片受体磷酸化增强慢性烧伤疼痛

期刊:Journal of Pain Research
影响因子:2.5
doi:10.2147/JPR.S529103
Zhu, Xunxi; Zhang, Yajun; Zhang, Qiqi; Zhang, Zhongjun
信号转导
磷酸化
PKC
发表日期：2025
文献求助 收藏

Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer

基因组预测 HER2 阴性乳腺癌新辅助化学免疫疗法反应和免疫疗法益处

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2024-009587
Xunxi Lu #, Zongchao Gou #, Hong Chen, Li Li, Fei Chen, Chunjuan Bao, Hong Bu
肿瘤
乳腺癌
发表日期：2024
文献求助 收藏

Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer

ER+/HER2-早期乳腺癌中ER与PR差异的预后意义

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-74608-w
Wu, Xiaoyan; Zhang, Wenchuan; Lu, Xunxi; Zhong, Xiaorong; Bu, Hong
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

D1018 with higher stability and excellent lipopolysaccharide binding affinity has potent anti-bacterial and anti-inflammatory activity

D1018具有更高的稳定性和优异的脂多糖结合亲和力，具有强大的抗菌和抗炎活性。

期刊:Frontiers in Microbiology
影响因子:4.5
doi:10.3389/fmicb.2022.1010017
Wu, Runzhe; Dong, Xunxi; Wang, Qiang; Zhang, Zirui; Wang, Jianhua; Wang, Xiao
发表日期：2022
文献求助 收藏